Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen, Technische Universität München, 80636, Munich, Germany.
DZHK (German Center for Cardiovascular Research) e.V., Partner Site Munich Heart Alliance, 80636, Munich, Germany.
Clin Res Cardiol. 2018 Aug;107(Suppl 2):2-9. doi: 10.1007/s00392-018-1324-1. Epub 2018 Jul 18.
As clinicians, we understand the development of atherosclerosis as a consequence of cholesterol deposition and inflammation in the arterial wall, both being triggered by traditional risk factors such as hypertension, hyperlipidaemia or diabetes mellitus. Another risk factor is genetic predisposition, as indicated by the predictive value of a positive family history. However, we had to wait until recently to appreciate the abundant contribution of genetic variation to the manifestation of atherosclerosis. Indeed, by now 164 chromosomal loci have been identified by genome-wide association studies (GWAS) to affect the risk of coronary artery disease. By design, practically all risk variants discovered by GWAS are frequently found in our population, resulting in the fact that principally every Western European individual carries between 130 and 190 risk alleles at the known, genome-wide significant loci (there are 0, 1, or 2 risk alleles per locus). One can assume that it is this widespread disposition that makes mankind susceptible to the detrimental effects of lifestyle factors, which likewise increase the risk of atherosclerosis. In this review, we summarize the recent genetic discoveries and attempt to group the multiple genetic risk variants in functional groups that may become actionable from a preventive or therapeutic perspective.
作为临床医生,我们了解动脉粥样硬化的发展是胆固醇在动脉壁沉积和炎症的结果,这两者都是由高血压、高脂血症或糖尿病等传统危险因素引发的。另一个危险因素是遗传易感性,阳性家族史就表明了这一点。然而,我们直到最近才认识到遗传变异在动脉粥样硬化表现中的大量贡献。事实上,通过全基因组关联研究(GWAS)已经确定了 164 个染色体位置会影响冠心病的风险。从设计上讲,GWAS 发现的几乎所有风险变异都在我们的人群中经常发现,因此实际上每个西欧个体在已知的全基因组显著位置都携带 130 到 190 个风险等位基因(每个位置有 0、1 或 2 个风险等位基因)。可以假设正是这种广泛的遗传倾向使人类容易受到生活方式因素的不利影响,而这些因素同样会增加动脉粥样硬化的风险。在这篇综述中,我们总结了最近的遗传发现,并试图将多个遗传风险变异分组到可能具有预防或治疗意义的功能组中。